{"SPADE_UN_09706": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2009/0215699 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2009_0215699_A1", "Patent Type": "Patent Application", "Publication Date": "2009-8-27", "Family Info": "CA2592888A1,EP1838333A1,WO2006072579A1", "Patent Title": "Pharmaceutically Active Antiviral Peptides.", "Abstract": "The inventive peptides were found to have strong antiviral activity against HIV in general and particularly strong drug-resistant HIV activity without exerting any toxic or antiproliferative effects on cells. Consequently, using of the inventive peptides improves the conventional HIV therapy with its toxic side effects."}], "Sequence Information": {"SPADE ID": "SPADE_UN_09706", "Sequence": "RLYLRLLLGY", "Sequence Length": 10, "Peptide Name": "Sequence 23 from Patent US 20090215699", "Source": "Synthetic construct", "Biological Activity": ["Antimicrobial", "Antiviral"], "Frequent Amino Acids": "LRY", "Absent Amino Acids": "ACDEFHIKMNOPQSTUVW", "Basic Residues": 2, "Acidic Residues": 0, "Hydrophobic Residues": 7, "Polar Residues": 4, "Positive Residues": 2, "Negative Residues": 0, "Mass": 1279.57, "PI": 9.99, "Net Charge": 2, "Hydrophobicity": 0.7, "Similar Sequences": [{"SPADE_ID": "SPADE_N_05892", "Similarity": 1.0, "Sequence": "ATCYCRTGRCATRESLSGVCEISGRLY"}, {"SPADE_ID": "SPADE_N_05899", "Similarity": 1.0, "Sequence": "CRTGRCATRESLSGVCEISGRLY"}, {"SPADE_ID": "SPADE_N_05902", "Similarity": 1.0, "Sequence": "TGRCATRESLSGVCEISGRLY"}]}}}